Koshinski Asset Management Inc. grew its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 16.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,624 shares of the pharmacy operator’s stock after purchasing an additional 1,515 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $832,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of WBA. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% during the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 5 shares during the period. Tarbox Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares in the last quarter. Webster Bank N. A. lifted its holdings in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares in the last quarter. MCF Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 68.2% in the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after buying an additional 780 shares in the last quarter. Finally, Founders Capital Management purchased a new stake in shares of Walgreens Boots Alliance in the first quarter worth about $161,000. Hedge funds and other institutional investors own 60.16% of the company’s stock.

A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a report on Saturday. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Finally, UBS AG reissued a “buy” rating and issued a $96.00 price target (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $91.81.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 13.50% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.63% on Monday, hitting $83.02. 1,946,774 shares of the stock traded hands. The firm has a 50 day moving average price of $81.26 and a 200 day moving average price of $81.99. The firm has a market cap of $88.84 billion, a PE ratio of 20.96 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. Walgreens Boots Alliance’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.18 EPS. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

Walgreens Boots Alliance declared that its board has initiated a share repurchase program on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/18/koshinski-asset-management-inc-raises-holdings-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.